135 related articles for article (PubMed ID: 1979656)
1. Mitochondrial DNA analysis in Parkinson's disease.
Schapira AH; Holt IJ; Sweeney M; Harding AE; Jenner P; Marsden CD
Mov Disord; 1990; 5(4):294-7. PubMed ID: 1979656
[TBL] [Abstract][Full Text] [Related]
2. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
3. Iron-dependent enzymes in Parkinson's disease.
Reichmann H; Janetzky B; Riederer P
J Neural Transm Suppl; 1995; 46():157-64. PubMed ID: 8821051
[TBL] [Abstract][Full Text] [Related]
4. The 'common deletion' is not increased in parkinsonian substantia nigra as shown by competitive polymerase chain reaction.
Kösel S; Egensperger R; Schnopp NM; Graeber MB
Mov Disord; 1997 Sep; 12(5):639-45. PubMed ID: 9380043
[TBL] [Abstract][Full Text] [Related]
5. Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal.
Schapira AH
Mov Disord; 1994 Mar; 9(2):125-38. PubMed ID: 8196673
[TBL] [Abstract][Full Text] [Related]
6. Complex I, iron, and ferritin in Parkinson's disease substantia nigra.
Mann VM; Cooper JM; Daniel SE; Srai K; Jenner P; Marsden CD; Schapira AH
Ann Neurol; 1994 Dec; 36(6):876-81. PubMed ID: 7998774
[TBL] [Abstract][Full Text] [Related]
7. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.
Schapira AH; Mann VM; Cooper JM; Dexter D; Daniel SE; Jenner P; Clark JB; Marsden CD
J Neurochem; 1990 Dec; 55(6):2142-5. PubMed ID: 2121905
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial complex I deficiency in Parkinson's disease.
Schapira AH; Cooper JM; Dexter D; Clark JB; Jenner P; Marsden CD
J Neurochem; 1990 Mar; 54(3):823-7. PubMed ID: 2154550
[TBL] [Abstract][Full Text] [Related]
9. Absence of the mitochondrial A7237T mutation in Parkinson's disease.
Lücking CB; Kösel S; Mehraein P; Graeber MB
Biochem Biophys Res Commun; 1995 Jun; 211(2):700-4. PubMed ID: 7794285
[TBL] [Abstract][Full Text] [Related]
10. Presymptomatic detection of Parkinson's disease.
Jenner P
J Neural Transm Suppl; 1993; 40():23-36. PubMed ID: 8294898
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease and the electron transport chain in postmortem brain.
Reichmann H; Lestienne P; Jellinger K; Riederer P
Adv Neurol; 1993; 60():297-9. PubMed ID: 8380522
[No Abstract] [Full Text] [Related]
12. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Jenner P; Marsden CD
J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
[TBL] [Abstract][Full Text] [Related]
13. L-dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain.
Cooper JM; Daniel SE; Marsden CD; Schapira AH
Mov Disord; 1995 May; 10(3):295-7. PubMed ID: 7651446
[TBL] [Abstract][Full Text] [Related]
14. PCR analysis of platelet mtDNA: lack of specific changes in Parkinson's disease.
Sandy MS; Langston JW; Smith MT; Di Monte DA
Mov Disord; 1993; 8(1):74-82. PubMed ID: 8419811
[TBL] [Abstract][Full Text] [Related]
15. Regional heterogeneity of mtDNA heteroplasmy in parkinsonian brain.
Schnopp NM; Kösel S; Egensperger R; Graeber MB
Clin Neuropathol; 1996; 15(6):348-52. PubMed ID: 8937782
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities of the electron transport chain in idiopathic Parkinson's disease.
Parker WD; Boyson SJ; Parks JK
Ann Neurol; 1989 Dec; 26(6):719-23. PubMed ID: 2557792
[TBL] [Abstract][Full Text] [Related]
17. Detrimental deletions: mitochondria, aging and Parkinson's disease.
Biskup S; Moore DJ
Bioessays; 2006 Oct; 28(10):963-7. PubMed ID: 16998822
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA and Parkinson's disease.
Di Monte DA
Neurology; 1991 May; 41(5 Suppl 2):38-42; discussion 42-3. PubMed ID: 1904141
[TBL] [Abstract][Full Text] [Related]
19. Oxidative mechanisms in nigral cell death in Parkinson's disease.
Jenner P
Mov Disord; 1998; 13 Suppl 1():24-34. PubMed ID: 9613715
[TBL] [Abstract][Full Text] [Related]
20. Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys.
Forno LS; Langston JW; DeLanney LE; Irwin I; Ricaurte GA
Ann Neurol; 1986 Oct; 20(4):449-55. PubMed ID: 3024555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
